Author： van Besien Koen Furman Richard R.
Publisher： Informa Healthcare
ISSN： 1042-8194
Source： Leukemia and Lymphoma, Vol.55, Iss.6, 2014-06, pp. : 1221-1222
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Role of microRNAs in chronic lymphocytic leukemia (Review)
Molecular Medicine Reports, Vol. 8, Iss. 3, 2013-09 ,pp. :
Access to resources
Recommend
Alemtuzumab in chronic lymphocytic leukemia
By James Danelle F Kipps Thomas J
Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. :
By Andritsos Leslie Khoury Hanna
Current Treatment Options in Oncology, Vol. 3, Iss. 3, 2002-06 ,pp. :
BRAF mutations in chronic lymphocytic leukemia
By Jebaraj Billy Michael Chelliah
Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. :
Recent Advances in Chronic Lymphocytic Leukemia
By Abbott Brian
Cancer Investigation, Vol. 24, Iss. 3, 2006-05 ,pp. :